At present, the company has established an advanced research and development system for new drugs and has a number of core technologies with independent intellectual property rights. At present, more than 10 clinical approvals have been obtained, and 5 products have been approved for marketing. The company has a world-class R&D laboratory and research environment, and has established long-term and stable strategic partnerships with many well-known multinational companies abroad. Ted company is based in China, looking at the world, aiming at developing innovative drugs with independent intellectual property rights and taking scientific and technological pharmaceutical enterprises as its development purpose. By constantly improving the core competitiveness of products and striving to open up the technical field of new preparations, it has always been in a leading position in the research and development of new drugs in China, thus providing high-quality new drug products for improving people's health and quality of life.
Perfect quality management
Adhering to the quality policy of "quality first, patient first", the company has established a perfect quality management system, strictly managed all links in the whole process of drug production, and ensured stable, unified, safe and effective drug quality. It passed GMP certification in China in 2005 and Japanese GMP certification in 2008.
Advanced production equipment
The building area of the production plant is15000m2, which can produce injections, oral tablets and external patches, all of which adopt international advanced production equipment. Among them, the injection production line adopts a specially customized closed large-scale automatic liquid preparation system, which has reached the international advanced level.